UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detection of a Sexually Transmitted Hepatitis C Virus Protease Inhibitor-Resistance Variant in a Human Immunodeficiency Virus–Infected Homosexual Man

Gastroenterology (New York, N.Y. 1943), 2014-09, Vol.147 (3), p.599-601.e1

2014

Volltextzugriff (PDF)

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

PloS one, 2010-10, Vol.5 (10), p.e13771

2010

Volltextzugriff (PDF)

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

AIDS (London), 2000-03, Vol.14 (4), p.397-403

2000

Volltextzugriff (PDF)

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons

HIV medicine, 2016-02, Vol.17 (2), p.83-88

2016

Volltextzugriff (PDF)

Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures

Antiviral research, 2018-07, Vol.155, p.106-114

2018

Volltextzugriff (PDF)

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

Journal of acquired immune deficiency syndromes (1999), 2015-07, Vol.69 (3), p.348-354

2015

Volltextzugriff (PDF)

Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status

Journal of antimicrobial chemotherapy, 2015-12, Vol.70 (12), p.3332-3338

2015

Volltextzugriff (PDF)

Clinical use of telaprevir: stopping rules, predicting response, treatment length, and management of adverse effects

Enfermedades infecciosas y microbiologia clinica, 2013-07, Vol.31 Suppl 3, p.19

2013

Volltextzugriff (PDF)

The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

Liver transplantation, 2009-09, Vol.15 (9), p.1133-1141

2009

Volltextzugriff (PDF)

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV

AIDS (London), 2015-03, Vol.29 (5), p.571-581

2015

Volltextzugriff (PDF)

Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations

PloS one, 2014-03, Vol.9 (3), p.e90710-e90710

2014

Volltextzugriff (PDF)

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection

Clinical infectious diseases, 2016-06, Vol.62 (12), p.1578-1585

2016

Volltextzugriff (PDF)

Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients

Journal of viral hepatitis, 2003-03, Vol.10 (2), p.118-125

2003

Volltextzugriff (PDF)

Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort

HIV medicine, 2014-02, Vol.15 (2), p.86-97

2014

Volltextzugriff (PDF)

HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)

Enfermedades infecciosas y microbiología clínica, 2009-08, Vol.27 (7), p.380-388

2009

Volltextzugriff (PDF)

Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients

Medicina clínica, 2010-10, Vol.135 (11), p.485-490

2010

Volltextzugriff (PDF)

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment

Antiviral therapy, 2010, Vol.15 (3), p.333-342

2010

Volltextzugriff (PDF)

Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia

Enfermedades infecciosas y microbiología clínica, 2005-06, Vol.23 (6), p.349

2005

Volltextzugriff (PDF)

Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/l

AIDS (London), 1996-09, Vol.10 (11), p.F39-F44

1996

Volltextzugriff (PDF)

Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC

AIDS (London), 1996-12, Vol.10 (14), p.F61-F66

1996

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaViral Diseases Of The Lymphoid Tissue And The Blood. Aids

ThemaViral Load

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Englisch
(18)
Spanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of a Sexually Transmitted Hepatitis C Virus Protease Inhibitor-Resistance Variant in a Human Immunodeficiency Virus–Infected Homosexual Man

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons

Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status

Clinical use of telaprevir: stopping rules, predicting response, treatment length, and management of adverse effects

The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV

Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection

Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients

Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort

Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-08)

HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)

Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment

Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia

Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/l

Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC

Aktive Filter

Suchergebnisse filtern